safinamide has been researched along with dapagliflozin in 1 studies
Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (dapagliflozin) | Trials (dapagliflozin) | Recent Studies (post-2010) (dapagliflozin) |
---|---|---|---|---|---|
199 | 29 | 159 | 1,478 | 368 | 1,407 |
Protein | Taxonomy | safinamide (IC50) | dapagliflozin (IC50) |
---|---|---|---|
Sodium/glucose cotransporter 1 | Homo sapiens (human) | 1.1661 | |
Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0022 | |
Sodium/myo-inositol cotransporter 2 | Homo sapiens (human) | 0.38 | |
Solute carrier family 5 member 4 | Homo sapiens (human) | 0.0014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowles, K; Bradshaw, A; Meosky, K; Mospan, C; Mospan, G; Vance, S | 1 |
1 other study(ies) available for safinamide and dapagliflozin
Article | Year |
---|---|
Drug updates and approvals: 2017 in review.
Topics: Adamantane; Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Benzylamines; Dipeptides; Drug Approval; Drug Combinations; Glucosides; Humans; Oxymetazoline; Primary Health Care; United States; United States Food and Drug Administration | 2017 |